LobbyingWillow Laboratories lobbying by quarter
Willow Laboratories's latest lobbying report covers Q3 2026, at under $5,000. Its first report covers Q3 2025; the issues it reports most are Financial Institutions/Investments/Securities and Health Issues.
Willow Laboratories
- Latest quarter
- $0
- Q3 2026 · 1 reports
- Last 12 months
- $0
- Last 4 quarters
- vs last quarter
- No record
- Q3 2026 against the quarter before
- First report
- Q3 2025
- The first quarter a report named it
Lobbying by quarter
No lobbying spend in this period.
| Quarter | Amount | Reports |
|---|---|---|
| Q3 2025 | $0 | 1 |
| Q4 2025 | $0 | 1 |
| Q1 2026 | $0 | 1 |
| Q2 2026 | $0 | 1 |
| Q3 2026 | $0 | 1 |
By issue
- Financial institutions and securities$0 · 5 reports
- Health issues$0 · 5 reports
- Medicare and Medicaid$0 · 5 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES5 reports
- SENATE5 reports
- Health & Human Services, Dept of (HHS)1 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-houseWillow Laboratories | $0 | 5 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 09/30for Q3 | In-house | Under $5,000 |
| 06/18for Q2 | In-house | Under $5,000 |
| 04/01for Q1 | In-house | Under $5,000 |
| 03/05for Q4 2025 | In-house | Under $5,000 |
| 25/12/15for Q4 2025 | In-house | Under $5,000 |
| 25/10/01for Q3 2025 | In-house | Under $5,000 |
| 25/10/01for Q3 2025 | In-house | Under $5,000 |
| 25/08/01for Q3 2025 | In-house | Under $5,000 |